METHODS AND REAGENTS FOR ZIKA VIRUS IMMUNOASSAYS

    公开(公告)号:US20220034882A1

    公开(公告)日:2022-02-03

    申请号:US17250857

    申请日:2019-09-18

    Abstract: Disclosed herein are immunoassay methods and reagents for detecting anti-Zika IgM antibody in a biological sample from a subject and/or diagnosing Zika virus infection in a subject. Also disclosed are algorithms for implementing the disclosed methods. The disclosed immunoassay methods, reagents, and algorithms enable efficient and reliable qualitative detection of anti-Zika virus antibodies and rapid determination of presumptive positive results for Zika virus infection in human subjects.

    METHODS AND REAGENTS FOR ZIKA VIRUS IMMUNOASSAYS

    公开(公告)号:US20230152321A1

    公开(公告)日:2023-05-18

    申请号:US18153344

    申请日:2023-01-11

    CPC classification number: G01N33/56983 G01N2333/18 G01N2469/20

    Abstract: Disclosed herein are immunoassay methods and reagents for detecting anti-Zika IgM antibody in a biological sample from a subject and/or diagnosing Zika virus infection in a subject. Also disclosed are algorithms for implementing the disclosed methods. The disclosed immunoassay methods, reagents, and algorithms enable efficient and reliable qualitative detection of anti-Zika virus antibodies and rapid determination of presumptive positive results for Zika virus infection in human subjects.

    Methods and reagents for Zika virus immunoassays

    公开(公告)号:US11959917B2

    公开(公告)日:2024-04-16

    申请号:US17250857

    申请日:2019-09-18

    CPC classification number: G01N33/56983 G01N2333/18 G01N2469/20

    Abstract: Disclosed herein are immunoassay methods and reagents for detecting anti-Zika IgM antibody in a biological sample from a subject and/or diagnosing Zika virus infection in a subject. Also disclosed are algorithms for implementing the disclosed methods. The disclosed immunoassay methods, reagents, and algorithms enable efficient and reliable qualitative detection of anti-Zika virus antibodies and rapid determination of presumptive positive results for Zika virus infection in human subjects.

Patent Agency Ranking